Hashem M Farr, MD
Specialist · San Jose
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- 3
- 2 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
- California licence: Delinquent
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Farr’s office at (408) 297-7077 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C38276 · Delinquent
Licence status: Delinquent · since 1978 · expires 2024-07-31 · Mashhad University of Medical Sciences Aka Ferdowsi University.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Gastroenterology
Medicaid work
$10,636 in 2020
Medicaid paid $10,636 for 177 billed services this clinician did in 2020, up to 31 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Service | 43 | $6,988 |
| Long return visit (40+ min) | 55 | $1,482 |
| New patient visit (60+ min) | 19 | $960 |
| DIAGNOSTIC COLONOSCOPY | 31 | $629 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $467 |
| Infusion, normal saline solution , 1000 cc | 16 | $110 |
| 2020 | 177 | 6 | 31 | $10,636 |
| 2019 | 1,541 | 11 | 41 | $64,423 |
| 2018 | 2,111 | 13 | 47 | $63,827 |
See the largest Medicaid services in earlier years
2019
| DIAGNOSTIC COLONOSCOPY | 207 | $19,459 |
| Service | 93 | $12,132 |
| New patient visit (60+ min) | 292 | $9,776 |
| TISSUE EXAM BY PATHOLOGIST | 99 | $9,385 |
| Long return visit (40+ min) | 291 | $7,105 |
| Service | 154 | $3,815 |
| Upper gastrointestinal endoscopy with biopsy | 26 | $1,165 |
| Injection, midazolam hydrochloride, per 1 mg | 147 | $703 |
| Fentanyl citrate injection | 141 | $688 |
| Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 78 | $111 |
| Infusion, normal saline solution , 1000 cc | 13 | $84 |
2018
| TISSUE EXAM BY PATHOLOGIST | 243 | $33,272 |
| Service | 391 | $9,355 |
| DIAGNOSTIC COLONOSCOPY | 208 | $6,667 |
| New patient visit (60+ min) | 106 | $3,119 |
| Upper gastrointestinal endoscopy with biopsy | 84 | $2,032 |
| Infusion, normal saline solution , 1000 cc | 40 | $1,952 |
| Injection, midazolam hydrochloride, per 1 mg | 400 | $1,815 |
| Fentanyl citrate injection | 395 | $1,783 |
| Long return visit (40+ min) | 119 | $1,636 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 32 | $814 |
| New patient visit (45+ min) | 67 | $655 |
| COLONOSCOPY AND BIOPSY | 14 | $584 |
Drugs they prescribed that Part D paid
$266
Pharmacies billed $266 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 15) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
15 generic and 0 brand-name prescriptions · $266 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 15 | None | 0% (0) | 0% | $266 |
| 2023 | 18 | None | 0% (0) | None | $288 |
| 2022 | 24 | None | None | 0% | $341 |
| 2021 | 35 | None | 0% (0) | None | $2,225 |
| 2020 | 241 | 51 | 0% (0) | 28% | $130,219 |
| 2019 | 424 | 120 | 0% (0) | 38% | $132,348 |
| 2018 | 629 | 162 | None | 32% | $113,132 |
| 2017 | 753 | 191 | None | 39% | $268,078 |
| 2016 | 723 | 205 | 0% (0) | 36% | $414,139 |
| 2015 | 626 | 167 | None | 27% | $495,721 |
| 2014 | 777 | 205 | None | 25% | $185,756 |
| 2013 | 1,106 | 263 | 2% (23) | None | $113,848 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 4 drugs
| Linzess | 19 | $12,404 | $653 |
| Dexilant | 19 | $9,178 | $483 |
| Omeprazole | 84 | $1,240 | $15 |
| Atorvastatin | 18 | $212 | $12 |
2019: 7 drugs
| Linzess | 32 | $16,419 | $513 |
| Amitiza | 18 | $7,445 | $414 |
| Suprep | 56 | $5,534 | $99 |
| Omeprazole | 124 | $1,766 | $14 |
| Esomeprazole Magnesium | 18 | $1,344 | $75 |
| Lansoprazole | 15 | $825 | $55 |
| Atorvastatin | 17 | $310 | $18 |
2018: 12 drugs
| Dexilant | 29 | $15,654 | $540 |
| Linzess | 21 | $12,052 | $574 |
| Amitiza | 31 | $10,637 | $343 |
| Lyrica | 12 | $8,881 | $740 |
| Suprep | 53 | $4,956 | $94 |
| Esomeprazole Magnesium | 27 | $2,891 | $107 |
| Omeprazole | 187 | $2,388 | $13 |
| Sulfasalazine | 20 | $1,031 | $52 |
| Atorvastatin | 18 | $629 | $35 |
| Polyethylene Glycol 3350 | 28 | $577 | $21 |
| Ranitidine | 16 | $398 | $25 |
| Tamsulosin | 12 | $141 | $12 |
2017: 18 drugs
| Zegerid | 11 | $34,005 | $3,091 |
| Linzess | 71 | $30,879 | $435 |
| Amitiza | 44 | $14,090 | $320 |
| Dexilant | 34 | $12,838 | $378 |
| Lialda | 11 | $11,779 | $1,071 |
| Lyrica | 13 | $8,644 | $665 |
| Carafate | 15 | $4,720 | $315 |
| Suprep | 42 | $3,764 | $90 |
| Omeprazole | 189 | $3,066 | $16 |
| Polyethylene Glycol 3350 | 47 | $1,506 | $32 |
| Sulfasalazine | 23 | $1,105 | $48 |
| Tamsulosin | 12 | $541 | $45 |
| Atorvastatin | 25 | $397 | $16 |
| Peg 3350-Electrolyte | 21 | $353 | $17 |
| Ranitidine | 11 | $195 | $18 |
| Gavilyte-N | 12 | $181 | $15 |
| Pantoprazole | 16 | $157 | $10 |
| Metformin | 12 | $106 | $9 |
2016: 13 drugs
| Linzess | 35 | $14,496 | $414 |
| Amitiza | 33 | $11,392 | $345 |
| Dexilant | 32 | $9,906 | $310 |
| Canasa | 11 | $9,903 | $900 |
| Lyrica | 12 | $6,047 | $504 |
| Omeprazole | 209 | $3,286 | $16 |
| Polyethylene Glycol 3350 | 34 | $859 | $25 |
| Peg 3350-Electrolyte | 52 | $855 | $16 |
| Gavilyte-N | 31 | $511 | $16 |
| Sulfasalazine | 12 | $468 | $39 |
| Sucralfate | 17 | $425 | $25 |
| Atorvastatin | 16 | $288 | $18 |
| Pantoprazole | 13 | $170 | $13 |
2015: 18 drugs
| Harvoni | 11 | $343,833 | $31,258 |
| Canasa | 15 | $12,299 | $820 |
| Linzess | 22 | $6,550 | $298 |
| Dexilant | 16 | $4,474 | $280 |
| Prevacid | 12 | $3,452 | $288 |
| Amitiza | 11 | $3,443 | $313 |
| Omeprazole | 195 | $3,229 | $17 |
| Moviprep | 18 | $1,487 | $83 |
| Lansoprazole | 15 | $1,313 | $88 |
| Polyethylene Glycol 3350 | 27 | $592 | $22 |
| Sucralfate | 20 | $512 | $26 |
| Tamsulosin | 11 | $361 | $33 |
| Peg 3350-Electrolyte | 18 | $334 | $19 |
| Pantoprazole | 17 | $326 | $19 |
| Gavilyte-N | 16 | $304 | $19 |
| Gabapentin | 17 | $280 | $16 |
| Atorvastatin | 16 | $214 | $13 |
| Naproxen | 12 | $144 | $12 |
2014: 16 drugs
| Dexilant | 22 | $7,419 | $337 |
| Nexium | 13 | $6,057 | $466 |
| Linzess | 22 | $5,514 | $251 |
| Omeprazole | 256 | $5,201 | $20 |
| Moviprep | 29 | $2,381 | $82 |
| Lansoprazole | 23 | $1,557 | $68 |
| Polyethylene Glycol 3350 | 45 | $1,107 | $25 |
| Gabapentin | 13 | $595 | $46 |
| Peg-3350 | 30 | $564 | $19 |
| Sulfasalazine | 11 | $479 | $44 |
| Tamsulosin | 21 | $468 | $22 |
| Gavilyte-N | 14 | $291 | $21 |
| Levofloxacin | 12 | $169 | $14 |
| Metronidazole | 12 | $142 | $12 |
| Propranolol | 15 | $134 | $9 |
| Furosemide | 13 | $28 | $2 |
2013: 28 drugs
| Nexium | 38 | $16,750 | $441 |
| Dexilant | 72 | $16,183 | $225 |
| Omeprazole | 342 | $8,099 | $24 |
| Amitiza | 20 | $5,772 | $289 |
| Linzess | 11 | $2,660 | $242 |
| Lipitor | 13 | $2,598 | $200 |
| Lansoprazole | 18 | $2,077 | $115 |
| Halflytely-Bisacodyl | 19 | $1,299 | $68 |
| Polyethylene Glycol 3350 | 40 | $971 | $24 |
| Gabapentin | 26 | $916 | $35 |
| Peg-3350 With Flavor Packs | 46 | $897 | $19 |
| Atorvastatin | 19 | $661 | $35 |
| Peg 3350-Electrolyte | 14 | $576 | $41 |
| Sucralfate | 15 | $494 | $33 |
| Gavilyte-N | 22 | $453 | $21 |
| Tamsulosin | 19 | $438 | $23 |
| Spironolactone | 14 | $345 | $25 |
| Lisinopril | 34 | $275 | $8 |
| Tramadol | 12 | $207 | $17 |
| Metformin | 11 | $181 | $16 |
| Verapamil Er | 12 | $165 | $14 |
| Naproxen | 13 | $137 | $11 |
| Alendronate | 12 | $124 | $10 |
| Hydrochlorothiazide | 14 | $108 | $8 |
| Metoclopramide | 17 | $90 | $5 |
| Levothyroxine | 11 | $86 | $8 |
| Amlodipine Besylate | 13 | $70 | $5 |
| Furosemide | 11 | $32 | $3 |
Money from drug and device companies
$28 in 2020
| 2020 | 1 | 1 | None | $28 |
| 2019 | 6 | 10 | None | $219 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AbbVie | Mavyret | $28 | 1 payment
|
See the published payment
| AbbVie | Meals · 2020-11-10 | Mavyret | $28 |
See earlier years (2019)
2019: $219
| AbbVie | Mavyret | $67 | 3 payments
|
| Gilead Sciences | None | $44 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $37 | 2 payments
|
| Ferring Pharmaceuticals | Clenpiq | $33 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Amitiza | $22 | 1 payment
|
| Braintree Laboratories | Suprep Bowel Prep | $15 | 1 payment
|
Professional record
- NPI
- 1336164375
- Licence
- CA C38276California C38276: Delinquent · expires 2024-07-31
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 3366617
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 2375 Forest Ave, San Jose, CA, 95128
- NPI first listed
- 2006-07-12
- NPI last updated
- 2017-07-06
This is when the NPI record was last certified, not a medical board exam.